Martin Guimond, Ph.D. - Publications

Affiliations: 
2003 Université de Montréal, Montréal, Canada 
Area:
Biomedical Engineering, Immunology

51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Neidemire-Colley L, Robert J, Ackaoui A, Dorrance AM, Guimond M, Ranganathan P. Role of endothelial cells in graft-versus-host disease. Frontiers in Immunology. 13: 1033490. PMID 36505438 DOI: 10.3389/fimmu.2022.1033490  0.358
2021 Dorrance A, Moutuou M, Goda C, Sell NE, Kalyan S, Karunasiri M, Kulkarni R, Goulard M, Kolovich S, Rudich A, Naumann E, Ackaoui A, Bigras CE, Daudelin F, Garzon R, ... ... Guimond M, et al. Modulating endothelial cells with EGFL7 to diminish aGVHD after allogeneic bone marrow transplantation in mice. Blood Advances. PMID 34654057 DOI: 10.1182/bloodadvances.2021005498  0.365
2020 Silvestri G, Trotta R, Stramucci L, Ellis JJ, Harb JG, Neviani P, Wang S, Eisfeld AK, Walker CJ, Zhang B, Srutova K, Gambacorti-Passerini C, Pineda G, Jamieson CHM, Stagno F, ... ... Guimond M, et al. Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on Antiproliferative and PP2A-Activating Functions. Blood Cancer Discovery. 1: 48-67. PMID 32974613 DOI: 10.1158/0008-5472.BCD-19-0039  0.315
2020 Moutuou MM, Gauthier SD, Chen N, Leboeuf D, Guimond M. Studying Peripheral T Cell Homeostasis in Mice: A Concise Technical Review. Methods in Molecular Biology (Clifton, N.J.). 2111: 267-283. PMID 31933214 DOI: 10.1007/978-1-0716-0266-9_21  0.488
2019 Silvestri G, Trotta R, Stramucci L, Wang S, Eisfeld A, Zhang B, Srutova K, Pineda G, Jamieson C, Stagno F, Vigneri P, Nteliopoulos G, Guimond M, Hokland P, Deininger MW, et al. A 14q32.31 Genomic-Imprinted DLK1-DIO3 microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer Immunity Blood. 134: 4141-4141. DOI: 10.1182/Blood-2019-131113  0.451
2019 Trotta R, Silvestri G, Stramucci L, Marcucci G, Guimond M, Fan X, Baer M, Perrotti D. PC-12 Bone marrow microenvironment-induced miR-300 expression impairs natural killer cell proliferation and anti-tumor activity Journal of Acquired Immune Deficiency Syndromes. 81: 63. DOI: 10.1097/01.Qai.0000558015.84504.53  0.34
2018 Gauthier SD, Moutuou MM, Daudelin F, Leboeuf D, Guimond M. IL-7 Is the Limiting Homeostatic Factor that Constrains Homeostatic Proliferation of CD8 T Cells after Allogeneic Stem Cell Transplantation and Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30576835 DOI: 10.1016/J.Bbmt.2018.12.066  0.604
2018 Hillhouse EE, Thiant S, Moutuou MM, Lombard-Vadnais F, Parat R, Delisle JS, Ahmad I, Roy DC, Guimond M, Roy J, Lesage S. Double negative T cells levels correlate with chronic graft-versus-host disease severity. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30244108 DOI: 10.1016/J.Bbmt.2018.09.008  0.617
2018 Moutuou MM, Pagé G, Zaid I, Lesage S, Guimond M. Restoring T Cell Homeostasis After Allogeneic Stem Cell Transplantation; Principal Limitations and Future Challenges. Frontiers in Immunology. 9: 1237. PMID 29967605 DOI: 10.3389/Fimmu.2018.01237  0.479
2018 Trotta R, Silvestri G, Stramucci L, Guimond M, Marcucci G, Fan X, Baer MR, Perrotti D. Abstract 4736: Bone marrow microenvironment-induced miR-300 expression impairs natural killer cell proliferation and antitumor activity Cancer Research. 78: 4736-4736. DOI: 10.1158/1538-7445.Am2018-4736  0.442
2018 Silvestri G, Stramucci L, Ellis J, Harb J, Neviani P, Zhang B, Srutova K, Pineda G, Jamieson C, Calabretta B, Stagno F, Vigneri P, Nteliopoulos G, May P, Reid A, ... ... Guimond M, et al. Abstract 1134: The tumor suppressor activity of miR-300 is detrimental for leukemia development but required for leukemia stem cell maintenance Cancer Research. 78: 1134-1134. DOI: 10.1158/1538-7445.Am2018-1134  0.5
2018 Moutuou MM, Thiant S, Leboeuf D, Guimond M. Unsuspected role of Interleukin-7 produced by hematopoietic cells to prevent autoimmunity in Recombination-activating gene (RAG)-deficient mice Cytotherapy. 20. DOI: 10.1016/J.Jcyt.2018.02.357  0.367
2017 Thiant S, Moutuou MM, Laflamme P, Sidi Boumedine R, Leboeuf DM, Busque L, Roy J, Guimond M. Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients. Blood Cancer Journal. 7: e551. PMID 28387753 DOI: 10.1038/Bcj.2017.29  0.532
2016 Thiant S, Moutuou MM, Leboeuf D, Guimond M. Homeostatic cytokines in immune reconstitution and graft-versus-host disease. Cytokine. 82: 24-32. PMID 26795458 DOI: 10.1016/J.Cyto.2016.01.003  0.484
2015 Gauthier SD, Leboeuf D, Manuguerra-Gagné R, Gaboury L, Guimond M. Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4(+) T Cells after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1721-31. PMID 26151303 DOI: 10.1016/J.Bbmt.2015.06.019  0.595
2015 Thiant S, Moutuou MM, Laflamme P, Boumedine RS, Larochelle F, Leboeuf D, Roy D, Guimond M. Disruption of the Peripheral Lymphoid Niche Contributes to Lymphopenia in CML Patients Undergoing Imatinib Treatments Blood. 126: 5165-5165. DOI: 10.1182/Blood.V126.23.5165.5165  0.643
2015 Thiant S, Roy J, Trottier J, Giard M, Parat R, Roy D, Guimond M. The Impact of Graft-Versus-Host Disease on Dendritic Cell Homeostasis and Their Potential Use As Biomarker to Predict the Severity of Chronic Graft-Versus-Host Disease Blood. 126: 3149-3149. DOI: 10.1182/Blood.V126.23.3149.3149  0.639
2013 Hennion-Tscheltzoff O, Leboeuf D, Gauthier SD, Dupuis M, Assouline B, Grégoire A, Thiant S, Guimond M. TCR triggering modulates the responsiveness and homeostatic proliferation of CD4+ thymic emigrants to IL-7 therapy. Blood. 121: 4684-93. PMID 23613523 DOI: 10.1182/Blood-2012-09-458174  0.516
2013 Walsh MP, Duncan B, Larabee S, Krauss A, Davis JP, Cui Y, Kim SY, Guimond M, Bachovchin W, Fry TJ. Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors. Plos One. 8: e58860. PMID 23554941 DOI: 10.1371/Journal.Pone.0058860  0.409
2013 Capitini CM, Nasholm NM, Duncan BB, Guimond M, Fry TJ. Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis. Journal of Immunology (Baltimore, Md. : 1950). 190: 1351-9. PMID 23275602 DOI: 10.4049/Jimmunol.1200391  0.514
2013 Gauthier S, Guimond M. The Restorative Effect of Flt3-Ligand and IL-7 On CD4+ T Cell Homeostatic Proliferation During Graft-Versus-Host Disease Biology of Blood and Marrow Transplantation. 19. DOI: 10.1016/J.Bbmt.2012.11.223  0.514
2010 Shriner AK, Liu H, Sun G, Guimond M, Alugupalli KR. IL-7-dependent B lymphocytes are essential for the anti-polysaccharide response and protective immunity to Streptococcus pneumoniae. Journal of Immunology (Baltimore, Md. : 1950). 185: 525-31. PMID 20505146 DOI: 10.4049/Jimmunol.0902841  0.378
2010 Fewkes NM, Krauss AC, Guimond M, Meadors JL, Dobre S, Mackall CL. Pharmacologic modulation of niche accessibility via tyrosine kinase inhibition enhances marrow and thymic engraftment after hematopoietic stem cell transplantation. Blood. 115: 4120-9. PMID 20231424 DOI: 10.1182/Blood-2009-10-248898  0.446
2010 Guimond M, Freud AG, Mao HC, Yu J, Blaser BW, Leong JW, Vandeusen JB, Dorrance A, Zhang J, Mackall CL, Caligiuri MA. In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. Journal of Immunology (Baltimore, Md. : 1950). 184: 2769-75. PMID 20142363 DOI: 10.4049/Jimmunol.0900685  0.458
2010 Capitini CM, Guimond M, Fry TJ. Gvhd Increases Apoptosis of CD8+, but Not CD4+, T Cells Expanded by Vaccines but Is Not Dependent on Fas Ligand Blood. 116: 2098-2098. DOI: 10.1182/Blood.V116.21.2098.2098  0.526
2010 Mackall CL, Guimond M. Reply to [ldquo]Is IL-7 from dendritic cells essential for the homeostasis of CD4+ T cells?[rdquo] Nature Immunology. 11: 548-548. DOI: 10.1038/Ni0710-548  0.553
2009 Cui Y, Zhang H, Meadors J, Poon R, Guimond M, Mackall CL. Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts. Blood. 114: 3831-40. PMID 19704119 DOI: 10.1182/Blood-2009-03-212134  0.479
2009 Reddy P, Arora M, Guimond M, Mackall CL. GVHD: a continuing barrier to the safety of allogeneic transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 162-8. PMID 19147099 DOI: 10.1016/J.Bbmt.2008.10.014  0.454
2009 Guimond M, Veenstra RG, Grindler DJ, Zhang H, Cui Y, Murphy RD, Kim SY, Na R, Hennighausen L, Kurtulus S, Erman B, Matzinger P, Merchant MS, Mackall CL. Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Nature Immunology. 10: 149-57. PMID 19136960 DOI: 10.1038/Ni.1695  0.546
2008 Dorrance AM, Liu S, Chong A, Pulley B, Nemer D, Guimond M, Yuan W, Chang D, Whitman SP, Marcucci G, Caligiuri MA. The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele. Blood. 112: 2508-11. PMID 18617636 DOI: 10.1182/Blood-2008-01-134338  0.323
2008 Guimond M, Leonard WJ, Spolski R, Rossi SW, Veenstra RG, Hollander GA, Mackall CL, Blazar BR. Thymic stromal lymphopoietin is not necessary or sufficient to mediate the thymopoietic effects of keratinocyte growth factor. Blood. 111: 969-70. PMID 18182587 DOI: 10.1182/Blood-2007-09-113316  0.517
2008 Krauss AC, Guimond M, Dobre S, Mackall CL. Tyrosine Kinase Inhibition with Sunitinib Facilitates Thymic Engraftment by Modulating Thymic Niche Accessibility Blood. 112: 72-72. DOI: 10.1182/Blood.V112.11.72.72  0.383
2008 Walsh M, Krauss AC, Davis JP, Kim SY, Guimond M, Mackall CL, Fry TJ. Dipeptidyl Peptidase Inhibition Accelerates Dendritic Cell Cross Priming of Tumor-Reactive T Cells Resulting in Regression of Established Tumors Blood. 112: 2579-2579. DOI: 10.1182/Blood.V112.11.2579.2579  0.436
2007 Opavsky R, Tsai SY, Guimond M, Arora A, Opavska J, Becknell B, Kaufmann M, Walton NA, Stephens JA, Fernandez SA, Muthusamy N, Felsher DW, Porcu P, Caligiuri MA, Leone G. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Proceedings of the National Academy of Sciences of the United States of America. 104: 15400-5. PMID 17881568 DOI: 10.1073/Pnas.0706307104  0.386
2007 Guimond M, Freud AG, Mao HC, Blaser BW, Lagemann GG, Vandeusen JB, Dorrance A, Ferketich AK, Cavalcanti M, Mackall CL, Caligiuri MA. Mechanism by Which Exogenous Administration of Flt3 Ligand (FL) Expands Natural Killer Cells In Vivo. Blood. 110: 2310-2310. DOI: 10.1182/Blood.V110.11.2310.2310  0.487
2007 Davis JP, Herby S, Walsh MP, Capitini CM, Guimond M, Wayne A, Fry TJ. Extracorporeal Photopheresis Diminishes Graft-Versus-Host-Disease and Modulates Dendritic Cell Cytokine Production. Blood. 110: 2177-2177. DOI: 10.1182/Blood.V110.11.2177.2177  0.475
2007 Capitini CM, Guimond M, Mackall CL, Fry TJ. GVHD Abrogates T Cell Responses to Dendritic Cell Vaccines but Not Vaccine-Induced Proliferation. Blood. 110: 1802-1802. DOI: 10.1182/Blood.V110.11.1802.1802  0.491
2007 Guimond M, Veenstra RG, Grindler DJ, Cui Y, Na R, Hennighausen L, Zhang H, Merchant MS, Mackall C. Interleukin-7 Produced by Antigen Presenting Cells Regulates the Homeostatic Peripheral Expansion of Naive CD4 T Cells. Blood. 110: 1333-1333. DOI: 10.1182/Blood.V110.11.1333.1333  0.561
2006 Dorrance AM, Liu S, Yuan W, Becknell B, Arnoczky KJ, Guimond M, Strout MP, Feng L, Nakamura T, Yu L, Rush LJ, Weinstein M, Leone G, Wu L, Ferketich A, et al. Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations. The Journal of Clinical Investigation. 116: 2707-16. PMID 16981007 DOI: 10.1172/Jci25546  0.317
2005 Zhang H, Chua KS, Guimond M, Kapoor V, Brown MV, Fleisher TA, Long LM, Bernstein D, Hill BJ, Douek DC, Berzofsky JA, Carter CS, Read EJ, Helman LJ, Mackall CL. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nature Medicine. 11: 1238-43. PMID 16227988 DOI: 10.1038/Nm1312  0.563
2005 Guimond M, Fry TJ, Mackall CL. Cytokine signals in T-cell homeostasis. Journal of Immunotherapy (Hagerstown, Md. : 1997). 28: 289-94. PMID 16000945 DOI: 10.1097/01.Cji.0000165356.03924.E7  0.552
2005 Freud AG, Becknell B, Roychowdhury S, Mao HC, Ferketich AK, Nuovo GJ, Hughes TL, Marburger TB, Sung J, Baiocchi RA, Guimond M, Caligiuri MA. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity. 22: 295-304. PMID 15780987 DOI: 10.1016/J.Immuni.2005.01.013  0.513
2005 Whitman SP, Liu S, Vukosavljevic T, Rush LJ, Yu L, Liu C, Klisovic MI, Maharry K, Guimond M, Strout MP, Becknell B, Dorrance A, Klisovic RB, Plass C, Bloomfield CD, et al. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood. 106: 345-52. PMID 15774615 DOI: 10.1182/Blood-2005-01-0204  0.329
2005 Blaser BW, Roychowdhury S, Kim DJ, Schwind NR, Bhatt D, Yuan W, Kusewitt DF, Ferketich AK, Caligiuri MA, Guimond M. Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease. Blood. 105: 894-901. PMID 15374888 DOI: 10.1182/Blood-2004-05-1687  0.497
2004 Roychowdhury S, May KF, Tzou KS, Lin T, Bhatt D, Freud AG, Guimond M, Ferketich AK, Liu Y, Caligiuri MA. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2. Cancer Research. 64: 8062-7. PMID 15520217 DOI: 10.1158/0008-5472.Can-04-1860  0.483
2004 Guimond M, Boumedine RS, Perreault C, Roy D. Defective Production of Myeloid Dendritic Cells Results from Skewing of Chronic Myelogenous Leukemia Progenitors. Blood. 104: 4700-4700. DOI: 10.1182/Blood.V104.11.4700.4700  0.621
2004 Freud AG, Becknell B, Roychowdhury S, Mao HC, Ferketich AK, Nuovo GJ, Hughes TL, Marburger TB, Sung J, Baiocchi RA, Guimond M, Caligiuri MA. A Novel Human CD34(+) Subset That Constitutively Expresses the High Affinity Interleukin-2 Receptor Traffics to Lymph Nodes and Differentiates into CD56Bright Natural Killer Cells. Blood. 104: 314-314. DOI: 10.1182/Blood.V104.11.314.314  0.516
2003 Klisovic DD, Katz SE, Effron D, Klisovic MI, Wickham J, Parthun MR, Guimond M, Marcucci G. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. Investigative Ophthalmology & Visual Science. 44: 2390-8. PMID 12766035 DOI: 10.1167/Iovs.02-1052  0.323
2003 Klisovic MI, Maghraby EA, Parthun MR, Guimond M, Sklenar AR, Whitman SP, Chan KK, Murphy T, Anon J, Archer KJ, Rush LJ, Plass C, Grever MR, Byrd JC, Marcucci G. Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells Leukemia. 17: 350-358. PMID 12592335 DOI: 10.1038/Sj.Leu.2402776  0.427
2002 Guimond M, Balassy A, Barrette M, Brochu S, Perreault C, Roy DC. P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells. Blood. 100: 375-82. PMID 12091325 DOI: 10.1182/Blood-2001-12-0353  0.619
2000 Guimond M, Busque L, Baron C, Bonny Y, Bélanger R, Mattioli J, Perreault C, Roy DC. Relapse after bone marrow transplantation: evidence for distinct immunological mechanisms between adult and paediatric populations. British Journal of Haematology. 109: 130-7. PMID 10848792 DOI: 10.1046/J.1365-2141.2000.01961.X  0.602
Show low-probability matches.